Jonathan Allan Stoke Therapeutics, Inc. (STOK) insider trading activity
Jonathan Allan is GENERAL COUNSEL & CORP SEC of Stoke Therapeutics, Inc.. Currently has a direct ownership of 19,631 shares of STOK, which is worth approximately $265,607. The most recent transaction as insider was on Aug 13, 2025, when has been sold 13,712 shares (Common Stock) at a price of $15.0 per share, resulting in proceeds of $205,680. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
19.6K
37.81%
3M change
655.62%
12M change
Total Value Held
$265,607
Jonathan Allan Transaction History
JA
Jonathan Allan
GENERAL COUNSEL & CORP SEC
Bedford, MA